Clinical Trial Update: Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM [NA]

View source ↗

Summary

A clinical trial is investigating how hyperglycemia and the antibiotic moxifloxacin affect the QTc interval in people with Type 2 diabetes; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Torsades De Pointes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Richmond Pharmacology Limited | Conditions: Diabetes Type 2, Hyperglycaemia (Diabetic) | NA | Status: RECRUITING